Nexien BioPharma (NXEN) Short Interest Ratio & Short Volume

Short interest is the volume of Nexien BioPharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 500 shares of NXEN short. 0.00% of Nexien BioPharma's shares are currently sold short. Learn More on Nexien BioPharma's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Nexien BioPharma's floating shares are currently sold short.

0.00% of Nexien BioPharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Nexien BioPharma: Tharimmune, Inc. (3.11%), Petros Pharmaceuticals, Inc. (14.90%), NovaBay Pharmaceuticals, Inc. (0.79%), Protagenic Therapeutics, Inc. (1.08%), Qualigen Therapeutics, Inc. (17.44%), Elevai Labs, Inc. (2.58%), Galmed Pharmaceuticals Ltd. (3.07%), ZyVersa Therapeutics, Inc. (4.29%), Psyence Biomedical Ltd. (32.06%), CERo Therapeutics Holdings, Inc. (14.02%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

Short selling NXEN is an investing strategy that aims to generate trading profit from Nexien BioPharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Nexien BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NXEN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NXEN, twice per month. The most recent reporting period available is March, 31 2025.